Clinical Trials Logo

Alopecia clinical trials

View clinical trials related to Alopecia.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06202560 Enrolling by invitation - Clinical trials for Frontal Fibrosing Alopecia

Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study

Tofacitinib
Start date: November 29, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to study the efficacy and safety of Tofacitinib therapy in Thai patients with recalcitrant frontal fibrosing alopecia. The main questions are 1. Does Tofacitinib significantly reduce Frontal Fibrosing Alopecia Severity Index (FFASI), Frontal Fibrosing Alopecia Severity Score (FFASS), Lichen planopillaris Activity Index (LPPAI) compared to baseline and after 16 weeks? 2. Is Tofacitinib significantly different for adverse events compared to baseline and after 16 weeks? Participants will have a check-up in clinical and investigation and then get prescribed oral Tofacitinib 5 mg twice a day for 12 weeks. After that, they will have follow-up every 4 weeks until week 16.

NCT ID: NCT06174441 Enrolling by invitation - Hair Loss Clinical Trials

The Effect of 24-week Dietary Intake of Food Supplements on Hair

TO-HAIR
Start date: January 8, 2024
Phase: N/A
Study type: Interventional

Purpose of this randomized, double-blind, placebo-controlled study will be to evaluate whether the daily use of novel dietary supplements over 24 weeks is able strengthen and promote growth of hairs, improve their density and thickness and reduce hair loss in adults with self-perceived thinning hair.

NCT ID: NCT05745389 Enrolling by invitation - Alopecia Areata Clinical Trials

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Start date: October 25, 2022
Phase:
Study type: Observational

Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.

NCT ID: NCT05084417 Enrolling by invitation - Psoriasis Clinical Trials

A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions

ClinPRO-DERM
Start date: June 9, 2023
Phase:
Study type: Observational [Patient Registry]

The primary goal of the study is to collect standardized patient and clinician reported outcome measures for patients diagnosed with a range of dermatological conditions in an academic clinical practice setting. By regularly measuring outcomes longitudinally in patients treated in a real-world setting, this study will provide valuable and necessary information as to the impact of both the disease and its treatments on patients over time and will inform the optimal clinical management of patients with living with dermatological disease.

NCT ID: NCT03898479 Enrolling by invitation - Alopecia Areata Clinical Trials

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Start date: April 4, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.

NCT ID: NCT03491267 Enrolling by invitation - Clinical trials for Central Centrifugal Cicatricial Alopecia (CCCA)

Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis

Start date: January 1, 2018
Phase: Early Phase 1
Study type: Interventional

The investigators have extensive evidence in mouse that wounding leads to the generation of new hair follicles in the skin. This can be an important new therapy for patients with scarring, but especially those with alopecia. The question is whether gentle wounding in human subjects can cause the generation of a new hair follicle. The plan is to first carefully map a small area of the scalp without hair follicles. Investigators will then try various modalities of gentle wounding (including fractionated Carbon Dioxide (CO2) laser, mild curetting) of the surface epithelium in the presence and absence of FDA approved topical medications (including retinoids). Investigators will then prospectively monitor the area for hair growth both by noninvasive visual monitoring (including photographs and dermoscopy) and biopsies. The outcomes of this study hopefully will allow new therapies for especially scarring alopecia conditions where hair follicles are completely lost and there are no current therapies.

NCT ID: NCT01651689 Enrolling by invitation - Alopecia Clinical Trials

Hair Counts From Vertical and Horizontal Sections of Scalp Biopsy SPecimens in Thai Population With Alopecia

ThaiScalpBx
Start date: October 2010
Phase: N/A
Study type: Observational

Hair disorders, expecialy scarring alopecia were diagnosed by scalp biopsy specimens in horizontal and vertical sections.(1-4) Data on hair density in Thais are lacking, although in Asians have more fewer hairs than whites.(5-7)Howevery, previous study from East Asian just had only one study and the data was more differently from West Asian and whites. Then this study was performed to evaluate hair density in Thais, and compared to previous study.